Third, although a previous report described GRP78/BiP in human non-small cell lung cancer [30], it remains unclear whether manipulation of VEGFR2 and/or GRP78/BiP levels within PPC cells represents an efficacious strategy to decrease tumor growth. Here, KDR is linked to non-small cell lung carcinoma.